This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korea to rationalize regulation across data, minerals under 'support and nurture'

( October 17, 2025, 03:09 GMT | Official Statement) -- MLex Summary: South Korea has announced a regulatory-rationalization package that shifts from “regulate first” to “support and nurture,” with concrete moves in data use, critical minerals and K-culture, among others. On data, the government will make it easier to use medical information from deceased persons for research aimed at protecting public health and will support remote, online use of health-insurance datasets for medical-AI research and industry. To shore up supply chains, officials will streamline import procedures and ease the current 3 percent tariff on waste resources containing lithium and rare earths. For K-culture, they will expand investment and tax support for a struggling film industry and move to immediately block overseas-hosted piracy sites targeting webtoons and dramas.The statement, in Korean, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login